Issue 02 · Foundation
And What That Has to Do With Recovery, Sleep, and That Stubborn Belly Fat
"14% per decade — what that number actually means"
Growth hormone secretion declines at roughly 14% per decade after age 30.
Do the math. If you're 45, you have roughly 80% of the GH output you had at 30. At 55, you're at 65–70%. By 60, most men are operating at 30–40% of peak.
This is called somatopause. It's normal. It happens to almost everyone. And it explains a lot of what men in their 40s and 50s experience when they're trying to maintain high physical performance.
Most people think growth hormone is about muscle and size. That's part of it, but it's not the main story — especially in the optimization context.
Here's how the axis works: your hypothalamus releases GHRH (Growth Hormone-Releasing Hormone), which tells your pituitary gland to release GH. GH travels to your liver, which converts it to IGF-1 (Insulin-like Growth Factor 1). IGF-1 is the primary effector — the thing that actually does the work in your tissues.
IGF-1 drives muscle protein synthesis, activates muscle satellite cells (the stem cells that repair and grow muscle), promotes fat breakdown (particularly visceral fat), supports collagen synthesis in tendons and ligaments, and maintains bone density.
What most people call "GH effects" — the recovery, the body composition, the tissue resilience — is mostly IGF-1. GH is the upstream signal; IGF-1 is what shows up at the job site.
When GH and IGF-1 decline, you feel it in specific ways.
Recovery slows. The connective tissue repair and muscle protein synthesis that used to happen overnight take longer. The injury that was a week of modified training in your 30s is a month-long setback in your late 40s. You're not imagining it and you're not getting soft. The biology changed.
Sleep gets worse. This is the one that surprised me most when I learned the mechanism. The largest GH pulse of the day occurs during deep sleep — specifically slow-wave sleep, stages 3 and 4. With age, slow-wave sleep declines. Less slow-wave sleep means smaller GH pulses. Smaller GH pulses mean poorer sleep architecture. It's a loop: the decline in GH degrades the sleep stage that produces GH.
Body composition shifts. GH/IGF-1 promotes fat mobilization, particularly visceral fat. As it declines, visceral fat tends to accumulate — even without meaningful changes in diet or training. The waist measurement that keeps slowly rising despite reasonable effort is partly this. It's not purely a willpower problem.
Tissue quality declines. Tendon, ligament, and cartilage health all depend on collagen synthesis driven partly by IGF-1. The structural integrity of your connective tissue — its resilience under repeated load — reflects your GH/IGF-1 levels accumulated over time.
The obvious question: if GH is declining, why not just inject growth hormone?
Some people do. And for clinical GH deficiency — measured and documented — there are legitimate medical reasons to use pharmaceutical HGH.
For general optimization, though, exogenous HGH has a problem most people don't know about: pulsatility.
GH is not released continuously. It pulses — about 6–12 times per day, with the big overnight pulse being the most significant. That pulsatile pattern is structurally required for the axis to function correctly. The pituitary and peripheral receptors need the refractory periods between pulses to maintain sensitivity.
Continuous GH — which is what daily injections create — causes receptor desensitization. The receptors downregulate. Ironically, continuous GH also produces less IGF-1 than pulsatile GH at the same total dose, because the liver's conversion mechanism is optimized for pulses, not steady-state levels.
You end up suppressing your own axis, desensitizing your receptors, and paying a significant cost (financially and hormonally) for a blunted result.
Secretagogues are the right solution. They work upstream — stimulating your pituitary to release its own GH, in its natural pulsatile pattern. Your axis stays intact. The feedback loops stay functional. You're amplifying what your body does rather than replacing it.
The standard approach: ipamorelin + CJC-1295 No DAC, injected 30–60 minutes before sleep.
Ipamorelin activates one GH-release pathway (the ghrelin receptor on pituitary cells). CJC-1295 No DAC activates a second pathway (the GHRH receptor). Combining both pathways produces synergistic GH release — not just additive. You're hitting two different signals at the same time that both say "release GH now."
Timed before sleep, you're arriving at the largest natural GH pulse window with both stimulatory signals primed. The pituitary was going to release GH anyway — you're just amplifying that release substantially.
One critical timing rule: no carbohydrates for 2–3 hours before the injection. Elevated blood sugar raises somatostatin — the suppressive signal — which blunts the GH response. A pasta dinner before your bedtime injection cuts your results meaningfully.
Sleep quality, almost universally.
Within 1–2 weeks, most men running this protocol notice deeper, more restorative sleep. Some report vivid dreams. This is the amplified slow-wave sleep — it's not subtle, and it arrives before anything else changes.
Recovery improvement comes next, weeks 2–4. Body composition shifts happen over months. Tissue quality is the longest arc — measured in months, not weeks.
This is not a dramatic transformation protocol. It's restoring a signaling system that was working better when you were younger. The effects are real, cumulative, and mostly felt rather than seen — until you look back at six months of training logs and realize you haven't had a significant setback in a while.
We'll cover the testosterone axis — the HPG (hypothalamic-pituitary-gonadal) axis and what's actually driving testosterone decline in men over 40. Spoiler: it's more complex than "testosterone just falls with age," and understanding the mechanism reveals where peptides can intervene before you commit to lifelong replacement therapy.